Suchergebnisse - "Vargas-Pozada EE"

Transforming coffee from an empirical beverage to a targeted nutritional intervention: health effects of coffee's core functional components on chronic diseases.

Autoren: Peng, Rui Lan, Mengqi Zhang, Yifei et al.

Quelle: Frontiers in Nutrition; 2025, p1-13, 13p

Elucidation of the effects of caffeine consumption on estrous cycle, hematology, and lipid profile of female Wistar rats.

Autoren: Ogunwole, Eunice Ogunmiluyi, Oluwafunmbi Ebenezer Adesida, Adedayo Oluwadamilola et al.

Quelle: Scientific Reports; 10/2/2025, Vol. 15 Issue 1, p1-12, 12p

Schlagwörter: CAFFEINE, ESTRUS, REPRODUCTIVE health, HEART metabolism, BLOOD lipids, LABORATORY rats, HEMATOLOGY, METABOLIC detoxification

Experimental Study on the Effect of Caffeine Hydrogel on the Expression of TGF -β1, α-SMA and Collagen in Hypertrophic Scar of Rabbit Ears.

Autoren: Ma, Jiu-Cheng Wang, Zhao-Nan Xi, Ming-Fan et al.

Quelle: Journal of Burn Care & Research; Jan/Feb2024, Vol. 45 Issue 1, p85-92, 8p

Schlagwörter: HYPERTROPHIC scars, HYDROGELS, CAFFEINE, COLLAGEN, SCARS

Caffeine mitigates ROS accumulation and attenuates motor neuron degeneration in the wobbler mouse model of amyotrophic lateral sclerosis.

Autoren: Epplen, Aimo Samuel Christian Rothöft, Maximilian Stahlke, Sarah et al.

Quelle: Cell Communication & Signaling; 9/10/2025, Vol. 23 Issue 1, p1-17, 17p

Schlagwörter: CAFFEINE, AMYOTROPHIC lateral sclerosis, ANIMAL models in research, OXIDATIVE stress, NAD (Coenzyme), NEURODEGENERATION, NEUROPROTECTIVE agents

Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death.

Autoren: Xi, Jianxin Lei, Shuangyin Chen, Jie et al.

Quelle: Cell Death Discovery; 6/19/2025, Vol. 11 Issue 1, p1-30, 30p

Inflammasomes: novel therapeutic targets for metabolic syndrome?

Autoren: Cao, Pengyu Yang, Yulin Zhang, Ningning et al.

Quelle: Frontiers in Endocrinology; 2025, p1-13, 13p

Schlagwörter: HIGH-fat diet, INSULIN resistance, METABOLIC syndrome, NATURAL immunity, METABOLIC disorders

The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver disease.

Autoren: Zhang, Lihui Liu, Sutong Zhao, Qing et al.

Quelle: Frontiers in Immunology; 2025, p1-17, 17p

Schlagwörter: ENDOPLASMIC reticulum stress, NON-alcoholic fatty liver disease, UBIQUITIN ligases, POST-translational modification, DEUBIQUITINATING enzymes

Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation.

Autoren: Wang, Zheng Qiu, Hairong Yang, Yang et al.

Quelle: Hereditas; 4/3/2024, Vol. 161 Issue 1, p1-13, 13p

Schlagwörter: NON-alcoholic fatty liver disease, MOLECULAR docking, FATTY liver, ANIMAL experimentation, PHARMACOLOGY

Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization.

Autoren: Jiang, Keqing Lu, Shibang Li, Dongxiao et al.

Quelle: Journal of Gastroenterology; Sep2023, Vol. 58 Issue 9, p894-907, 14p

Schlagwörter: HEPATIC fibrosis, HEPATITIS, FATTY liver, LABORATORY mice, TOLL-like receptors

Threshold effects between caffeine intake and urine flow rate: a population-based cross-sectional study.

Autoren: Huang, Yong Su, Huiyi Wang, Yingying et al.

Quelle: International Urology & Nephrology; Dec2024, Vol. 56 Issue 12, p3921-3932, 12p

Peptidoglycan- Chi3l1 interaction shapes gut microbiota in intestinal mucus layer.

Autoren: Yan Chen Ruizhi Yang Bin Qi et al.

Quelle: eLife; 10/7/2024, p1-23, 23p

New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis.

Autoren: Hu, Deyu Lai, Jiejuan Chen, Quanyu et al.

Quelle: Stem Cell Research & Therapy; 7/6/2024, Vol. 15 Issue 1, p1-20, 20p

Schlagwörter: HEPATIC fibrosis, BONE marrow cells, LIVER cells, LIVER regeneration, MESENCHYMAL stem cells, EMBRYONIC stem cells, BILE ducts, CIRRHOSIS of the liver

The role of renal resistive index as an early noninvasive predictor of renal dysfunction and relation to estimated glomerular filtration rate in nonalcoholic fatty liver disease patients.

Autoren: Semeya, Atteyat A. Tabl, Hala A.-E. Al-Mihy, Naglaa F.

Quelle: Journal of Medicine in Scientific Research; 2024, Vol. 7 Issue 3, p46-55, 10p

Schlagwörter: GLOMERULAR filtration rate, NON-alcoholic fatty liver disease, KIDNEY physiology, FIBROSIS, BIOMARKERS, KIDNEY diseases

Caffeine and neonatal acute kidney injury.

Autoren: Yang, Kun Liu, Jinjing He, Ting et al.

Quelle: Pediatric Nephrology; May2024, Vol. 39 Issue 5, p1355-1367, 13p

Schlagwörter: CAFFEINE, AUTOPHAGY, GUT microbiota, ENDOPLASMIC reticulum, ACUTE kidney failure in children, OXIDATIVE stress, MITOCHONDRIAL pathology

The importance of fundamental pharmacology in fighting liver diseases.

Autoren: Vargas-Pozada, Eduardo E. Ramos-Tovar, Erika Muriel, Pablo

Quelle: Annals of Hepatology: Official Journal of the Mexican Association of Hepatology; Mar/Apr2024, Vol. 29 Issue 2, p1-2, 2p

Schlagwörter: LIVER diseases, HEPATIC fibrosis, EXTRACELLULAR matrix proteins, TRANSFORMING growth factors-beta, NF-kappa B

Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways.

Autoren: Ren, Guanghui Bai, Changchuan Yi, Sitong et al.

Quelle: Journal of Innate Immunity; 2024, Vol. 16 Issue 1, p45-55, 11p

潜在抗肝纤维化药物与靶点相关信号通路研究进展. (Chinese)

Alternate Title: Research advances in signaling pathways associated with potential anti-liver fibrosis drugs and targets. (English)

Autoren: 周 鑫 王 智 何雪茹 et al.

Quelle: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi; Dec2023, Vol. 39 Issue 12, p2932-2941, 10p

Parathyroid hormone receptor-1 signaling aggravates hepatic fibrosis through upregulating cAMP response element-binding protein-like 2.

Autoren: Ting Hong Xuelian Xiong Yaqiong Chen et al.

Quelle: Hepatology (02709139); Dec2023, Vol. 78 Issue 6, p1763-1776, 14p

The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model.

Autoren: Márquez-Quiroga LV Cardoso-Lezama I Alarcón-Sánchez BR et al.

Quelle: Biochemical pharmacology [Biochem Pharmacol] 2025 Dec; Vol. 242 (Pt 3), pp. 117369. Date of Electronic Publication: 2025 Sep 25.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2968 (Electronic) Linking ISSN: 00062952 NLM ISO Abbreviation: Biochem Pharmacol Subsets: MEDLINE

MeSH-Schlagworte: Carcinoma, Hepatocellular*/metabolism , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/etiology , Disease Progression* , Fatty Liver*/metabolism , Fatty Liver*/pathology , Fatty Liver*/complications , Liver Neoplasms*/metabolism , Liver Neoplasms*/pathology , Liver Neoplasms*/etiology , Disease Models, Animal* , Liver Neoplasms, Experimental*/metabolism , Liver Neoplasms, Experimental*/pathology, Animals ; Male ; Rats, Inbred F344 ; Rats ; Diethylnitrosamine/toxicity

Coffee for the liver: a mechanistic approach.

Autoren: Vargas-Pozada EE Ramos-Tovar E Márquez-Quiroga LV et al.

Quelle: Biochemical pharmacology [Biochem Pharmacol] 2025 Dec; Vol. 242 (Pt 2), pp. 117338. Date of Electronic Publication: 2025 Sep 15.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2968 (Electronic) Linking ISSN: 00062952 NLM ISO Abbreviation: Biochem Pharmacol Subsets: MEDLINE

MeSH-Schlagworte: Coffee*/metabolism , Coffee*/chemistry , Liver*/drug effects , Liver*/metabolism , Liver*/pathology , Liver Diseases*/prevention & control , Liver Diseases*/metabolism, Humans ; Animals ; Oxidative Stress/drug effects ; Oxidative Stress/physiology ; Antioxidants/pharmacology